Assessing Fidelity in Yoga Interventions for Chemotherapy-Induced Peripheral Neuropathy: Decision-Making to Enhance Protocol Quality Adherence.

Autor: Saint K; University of Michigan Medical School, Ann Arbor, MI, USA., Paul T; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Patterson C; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Yang M; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Bao T; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Lou Galantino M; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Stockton University, Galloway, NJ, USA.; University of Witwatersrand, Johannesburg, South Africa.

Publikováno v: Integrative cancer therapies [Integr Cancer Ther] 2024 Jan-Dec; Vol. 23, pp. 15347354241261373.

P02.80. Safety and feasibility of modified chair-yoga on functional outcome among seniors at risk for falls

Autor: Galantino M, Greene L, Marsico R, Desai K, DeCesari J, MacKain N, Rinaldi S, Stevens M, Wurst V, Mao J

Publikováno v: BMC Complementary and Alternative Medicine, Vol 12, Iss Suppl 1, p P136 (2012)

Externí odkaz: https://doaj.org/article/fcf8db13bb8c4570b9af2a9795839702

CD8 ⁺ T cells contribute to survival in patients with COVID-19 and hematologic cancer.

Autor: Bange EM; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Han NA; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Wileyto P; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Kim JY; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Gouma S; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Robinson J; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Greenplate AR; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Hwee MA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Porterfield F; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Owoyemi O; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Naik K; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Zheng C; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Galantino M; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Weisman AR; Division of Pulmonary and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Ittner CAG; Division of Pulmonary and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Kugler EM; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Baxter AE; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Oniyide O; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, Presbyterian Hospital, Philadelphia, PA, USA., Agyekum RS; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, Presbyterian Hospital, Philadelphia, PA, USA., Dunn TG; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, Presbyterian Hospital, Philadelphia, PA, USA., Jones TK; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, Presbyterian Hospital, Philadelphia, PA, USA., Giannini HM; Division of Pulmonary and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Weirick ME; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., McAllister CM; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Babady NE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kumar A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Widman AJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., DeWolf S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Boutemine SR; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Roberts C; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Budzik KR; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Tollett S; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Wright C; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Perloff T; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, Pennsylvania Hospital, Philadelphia, NY, USA., Sun L; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Mathew D; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Giles JR; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy, Philadelphia, PA, USA., Oldridge DA; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Wu JE; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy, Philadelphia, PA, USA., Alanio C; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy, Philadelphia, PA, USA., Adamski S; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Garfall AL; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Vella LA; Department of Pediatrics, Perelman School of Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Kerr SJ; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology/Oncology, Department of Medicine, Lancaster General Hospital, Philadelphia, PA, USA., Cohen JV; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, Pennsylvania Hospital, Philadelphia, NY, USA., Oyer RA; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology/Oncology, Department of Medicine, Lancaster General Hospital, Philadelphia, PA, USA., Massa R; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, Presbyterian Hospital, Philadelphia, PA, USA., Maillard IP; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Maxwell KN; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Reilly JP; Division of Pulmonary and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Maslak PG; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Vonderheide RH; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy, Philadelphia, PA, USA., Wolchok JD; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Parker Institute for Cancer Immunotherapy, Philadelphia, PA, USA., Hensley SE; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Wherry EJ; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy, Philadelphia, PA, USA., Meyer NJ; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Division of Pulmonary and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., DeMichele AM; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Vardhana SA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. vardhans@mskcc.org.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. vardhans@mskcc.org.; Parker Institute for Cancer Immunotherapy, Philadelphia, PA, USA. vardhans@mskcc.org., Mamtani R; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. ronac.mamtani@pennmedicine.upenn.edu.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. ronac.mamtani@pennmedicine.upenn.edu., Huang AC; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. alexander.huang@pennmedicine.upenn.edu.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. alexander.huang@pennmedicine.upenn.edu.; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. alexander.huang@pennmedicine.upenn.edu.; Parker Institute for Cancer Immunotherapy, Philadelphia, PA, USA. alexander.huang@pennmedicine.upenn.edu.

Publikováno v: Nature medicine [Nat Med] 2021 Jul; Vol. 27 (7), pp. 1280-1289. Date of Electronic Publication: 2021 May 20.

CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer.

Autor: Bange EM; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Abramson Cancer Center, University of Pennsylvania., Han NA; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania., Wileyto P; Abramson Cancer Center, University of Pennsylvania.; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania., Kim JY; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania., Gouma S; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania., Robinson J; Abramson Cancer Center, University of Pennsylvania., Greenplate AR; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania., Porterfield F; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania., Owoyemi O; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania., Naik K; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania., Zheng C; Abramson Cancer Center, University of Pennsylvania., Galantino M; Abramson Cancer Center, University of Pennsylvania., Weisman AR; Division of Pulmonary and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania., Ittner CAG; Division of Pulmonary and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania., Kugler EM; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania., Baxter AE; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania., Oniyide O; Division of Pulmonary and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania., Agyekum RS; Division of Pulmonary and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania., Dunn TG; Division of Pulmonary and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania., Jones TK; Division of Pulmonary and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania., Giannini HM; Division of Pulmonary and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania., Weirick ME; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania., McAllister CM; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania., Babady NE; Department of Medicine, Memorial Sloan Kettering Cancer Center.; Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center., Kumar A; Department of Medicine, Memorial Sloan Kettering Cancer Center., Widman AJ; Department of Medicine, Memorial Sloan Kettering Cancer Center., DeWolf S; Department of Medicine, Memorial Sloan Kettering Cancer Center., Boutemine SR; Department of Medicine, Memorial Sloan Kettering Cancer Center., Roberts C; Abramson Cancer Center, University of Pennsylvania., Budzik KR; Abramson Cancer Center, University of Pennsylvania., Tollett S; Abramson Cancer Center, University of Pennsylvania., Wright C; Abramson Cancer Center, University of Pennsylvania., Perloff T; Abramson Cancer Center, University of Pennsylvania.; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, Pennsylvania Hospital., Sun L; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Abramson Cancer Center, University of Pennsylvania., Mathew D; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania., Giles JR; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania.; Parker Institute for Cancer Immunotherapy., Oldridge DA; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania., Wu JE; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania.; Parker Institute for Cancer Immunotherapy., Alanio C; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania.; Parker Institute for Cancer Immunotherapy., Adamski S; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania., Garfall AL; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Abramson Cancer Center, University of Pennsylvania., Vella L; Department of Pediatrics, Perelman School of Medicine, Children's Hospital of Philadelphia., Kerr SJ; Abramson Cancer Center, University of Pennsylvania.; Division of Hematology/Oncology, Department of Medicine, Lancaster General Hospital., Cohen JV; Abramson Cancer Center, University of Pennsylvania.; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, Pennsylvania Hospital., Oyer RA; Abramson Cancer Center, University of Pennsylvania.; Division of Hematology/Oncology, Department of Medicine, Lancaster General Hospital., Massa R; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Abramson Cancer Center, University of Pennsylvania.; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, Presbyterian Hospital., Maillard IP; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Abramson Cancer Center, University of Pennsylvania., Maxwell KN; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Abramson Cancer Center, University of Pennsylvania., Reilly JP; Division of Pulmonary and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania., Maslak PG; Department of Medicine, Memorial Sloan Kettering Cancer Center.; Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center., Vonderheide RH; Abramson Cancer Center, University of Pennsylvania.; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania.; Parker Institute for Cancer Immunotherapy., Wolchok JD; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center.; Department of Medicine, Memorial Sloan Kettering Cancer Center., Hensley SE; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania.; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania., Wherry EJ; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania.; Parker Institute for Cancer Immunotherapy., Meyer N; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania.; Division of Pulmonary and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania., DeMichele AM; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Abramson Cancer Center, University of Pennsylvania., Vardhana SA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center.; Department of Medicine, Memorial Sloan Kettering Cancer Center.; Parker Institute for Cancer Immunotherapy., Mamtani R; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Abramson Cancer Center, University of Pennsylvania., Huang AC; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Abramson Cancer Center, University of Pennsylvania.; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania.; Parker Institute for Cancer Immunotherapy.

Publikováno v: Research square [Res Sq] 2021 Feb 02. Date of Electronic Publication: 2021 Feb 02.

Le politiche nazionali e locali della sicurezza in alcuni Paesi dell'Europa occidentale

Autor: Farruggia, Francesca, Galantino, M. Grazia

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3686::e1e8a810ca2c12eb47f2af749555b4c9
http://hdl.handle.net/11573/872062